<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Microsimulation models are an increasingly common method for projecting disease outcomes to inform public health policies, for example, by assessing the cost effectiveness of treatments or the effects of prevention strategies (
 <xref rid="c41" ref-type="bibr" class="xref">Rutter et al. 2011</xref>). Health-related microsimulations have recently been used to assess the costs of osteoarthritis (
 <xref rid="c42" ref-type="bibr" class="xref">Sharif et al. 2015</xref>), to model the impact of quality of life on the outcomes of diabetes (
 <xref rid="c23" ref-type="bibr" class="xref">Hayes et al. 2011</xref>), to project the disability status of older Canadians to inform policies regarding aging populations (
 <xref rid="c32" ref-type="bibr" class="xref">Légaré and Décarie 2011</xref>), and to estimate the size of the HIV-positive population in the United Kingdom (
 <xref rid="c36" ref-type="bibr" class="xref">Nakagawa et al. 2016</xref>).
</p>
